A foamy virus vector system for stable and efficient rnai expression in mammalian cells

Human Gene Therapy

Volumn 22, Issue 10, 2011, Pages 1293-1303

  Papadaki, Magdalini ^a   Siapati, Elena Konstantina ^a   Vassilopoulos, George ^a,b  

^a BIOMEDICAL RESEARCH FOUNDATION   (Greece)

^b UNIVERSITY OF THESSALY   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

BCR ABL PROTEIN; DNA DIRECTED RNA POLYMERASE III; GREEN FLUORESCENT PROTEIN; SHORT HAIRPIN RNA; VIRUS VECTOR;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ARTICLE; BONE MARROW TRANSPLANTATION; CONTROLLED STUDY; EX VIVO STUDY; GENE DOSAGE; GENE SILENCING; GENE TARGETING; GENETIC TRANSDUCTION; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IN VIVO STUDY; MAMMAL CELL; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROMOTER REGION; RNA INTERFERENCE; RNA SEQUENCE; SPUMA VIRUS; VIRAL GENE DELIVERY SYSTEM;

ANIMALS; BONE MARROW TRANSPLANTATION; DNA PRIMERS; FLOW CYTOMETRY; FUSION PROTEINS, BCR-ABL; GENE SILENCING; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; HEMATOPOIETIC STEM CELLS; HUMANS; K562 CELLS; MICE; MICE, TRANSGENIC; MICROSCOPY, FLUORESCENCE; PROMOTER REGIONS, GENETIC; REAL-TIME POLYMERASE CHAIN REACTION; RNA INTERFERENCE; RNA POLYMERASE III; RNA, SMALL INTERFERING; SPUMAVIRUS; TRANSDUCTION, GENETIC;

HUMAN SPUMARETROVIRUS; MAMMALIA;

EID: 80155187764     PISSN: 10430342     EISSN: 15577422     Source Type: Journal    
DOI: 10.1089/hum.2010.223     Document Type: Article

References (48)

1. An, D.S., Qin, F.X., Auyeung, V.C., et al. (2006). Optimization and functional effects of stable short hairpin RNA expression in primary human lymphocytes via lentiviral vectors. Mol. Ther. 14, 494-504. (Pubitemid 44339392)
2. An, D.S., Donahue, R.E., Kamata, M., et al. (2007). Stable reduction of CCR5 by RNAi through hematopoietic stem cell transplant in non-human primates. Proc. Natl. Acad. Sci. U.S.A. 104, 13110-13115. (Pubitemid 351737601)
3. Andrianaki, A., Siapati, E.K., Hirata, R.K., et al. (2010). Dual transgene expression by foamy virus vectors carrying an endogenous bidirectional promoter. Gene Ther. 17, 380-388.
4. Boden, D., Pusch, O., Lee, F., et al. (2003). Promoter choice affects the potency of HIV-1 specific RNA interference. Nucleic Acids Res. 31, 5033-5038. (Pubitemid 37441870)
5. Bridge, A.J., Pebernard, S., Ducraux, A., et al. (2003). Induction of an interferon response by RNAi vectors in mammalian cells. Nat. Genet. 34, 263-264. (Pubitemid 36792856)
6. Brummelkamp, T.R., Bernards, R., and Agami, R. (2002). A system for stable expression of short interfering RNAs in mammalian cells. Science 296, 550-553. (Pubitemid 34408678)
7. Dykxhoorn, D.M., and Lieberman, J. (2005). The silent revolution: RNA interference as basic biology, research tool, and therapeutic. Annu. Rev. Med. 56, 401-423. (Pubitemid 40299790)
8. Fire, A., Xu, S., Montgomery, M.K., et al. (1998). Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 391, 806-811. (Pubitemid 28099681)
9. Fish, R.J., and Kruithof, E.K. (2004). Short-term cytotoxic effects and long-term instability of RNAi delivered using lentiviral vectors. BMC Mol. Biol. 5, 9.
10. Grimm, D., Streetz, K.L., Jopling, C.L., et al. (2006). Fatality in mice due to oversaturation of cellular microRNA/short hairpin RNA pathways. Nature 441, 537-541. (Pubitemid 44050158)
11. Hsieh, M.M., Langemeijer, S., Wynter, A., et al. (2007). Low-dose parenteral busulfan provides an extended window for the infusion of hematopoietic stem cells in murine hosts. Exp. Hematol. 35, 1415-1420. (Pubitemid 47302582)
12. Jackson, A.L., and Linsley, P.S. (2004). Noise amidst the silence: off-target effects of siRNAs?. Trends Genet. 20, 521-524. (Pubitemid 39314555)
13. Khan, A.A., Betel, D., Miller, M.L., et al. (2009). Transfection of small RNAs globally perturbs gene regulation by endogenous microRNAs. Nat. Biotechnol. 27, 549-555.
14. Khvorova, A., Reynolds, A., and Jayasena, S.D. (2003). Functional siRNAs and miRNAs exhibit strand bias. Cell 115, 209-216. (Pubitemid 37329584)
15. Kiem, H.P., Allen, J., Trobridge, G., et al. (2007). Foamy-virusmediated gene transfer to canine repopulating cells. Blood 109, 65-70. (Pubitemid 46053045)
16. Kim, D.H., and Rossi, J.J. (2007). Strategies for silencing human disease using RNA interference. Nat. Rev. Genet. 8, 173-184.
17. Kim, D.H., Behlke, M.A., Rose, S.D., et al. (2005). Synthetic dsRNA Dicer substrates enhance RNAi potency and efficacy. Nat. Biotechnol. 23, 222-226. (Pubitemid 40255333)
18. Maäkinen, P.I., Koponen, J.K., Kaärkkaäinen, A.M., et al. (2006). Stable RNA interference: comparison of U6 and H1 promoters in endothelial cells and in mouse brain. J. Gene Med. 8, 433-441.
19. McBride, J.L., Boudreau, R.L., Harper, S.Q., et al. (2008). Artificial miRNAs mitigate shRNA-mediated toxicity in the brain: implications for the therapeutic development of RNAi. Proc. Natl. Acad. Sci. U.S.A. 105, 5868-5873. (Pubitemid 351758464)
20. McLaughlin, J., Cheng, D., Singer, O., et al. (2007). Sustained suppression of Bcr-Abl-driven lymphoid leukemia by micro-RNA mimics. Proc. Natl. Acad. Sci. U.S.A. 104, 20501-20506.
21. McManus, M.T., and Sharp, P.A. (2002). Gene silencing in mammals by small interfering RNAs. Nat. Rev. Genet. 3, 737-747.
22. Mittal, V. (2004). Improving the efficiency of RNA interference in mammals. Nat. Rev. Genet. 5, 355-365. (Pubitemid 38529407)
23. Moore, M.D., McGarvey, M.J., Russell, R.A., et al. (2005). Stable inhibition of hepatitis B virus proteins by small interfering RNA expressed from viral vectors. J. Gene Med. 7, 918-925. (Pubitemid 41015540)
24. Okabe, M., Ikawa, M., Kominami, K., et al. (1997). 'Green mice' as a source of ubiquitous green cells. FEBS Lett. 407, 313-319. (Pubitemid 27199450)
25. Olejniczak, M., Galka, P., and Krzyzosiak, W.J. (2010). Sequence-non-specific effects of RNA interference triggers and microRNA regulators. (Review) Nucleic Acids Res. 38, 1-16.
26. Park, J., Nadeau, P., Zucali, J.R., et al. (2005). Inhibition of simian immunodeficiency virus by foamy virus vectors expressing siRNAs. Virology 343, 275-282. (Pubitemid 41599883)
27. Pebernard, S., and Iggo, R.D. (2004). Determinants of interferonstimulated gene induction by RNAi vectors. Differentiation 72, 103-111. (Pubitemid 41702145)
28. Rangatia, J., and Bonnet, D. (2006). Transient or long-term silencing of BCR-ABL alone induces cell cycle and proliferation arrest, apoptosis and differentiation. Leukemia 20, 68-76.
29. Rethwilm, A. (2007). Foamy virus vectors: an awaited alternative to gammaretro-and lentiviral vectors. Curr. Gene Ther. 7, 261-271. (Pubitemid 47232958)
30. Reynolds, A., Leake, D., Boese, Q., et al. (2004). Rational siRNA design for RNA interference. Nat. Biotechnol. 22, 326-330. (Pubitemid 38295766)
31. Reynolds, A., Anderson, E.M., Vermeulen, A., et al. (2006). Induction of the interferon response by siRNA is cell type-and duplex length-dependent. RNA 2, 988-993. (Pubitemid 43788117)
32. Robbins, M.A., Li, M., Leung, I., et al. (2006). Stable expression of shRNAs in human CD34+ progenitor cells can avoid induction of interferon responses to siRNAs in vitro. Nat. Biotechnol. 24, 566-571.
33. Sambrook, J., Fritsch, E.F., and Maniatis, T. (1989). Molecular Cloning: A Laboratory Manual, 2nd Ed. (Cold Spring Harbor Laboratory Press, Plainview, NY).
34. Scacheri, P.C., Rozenblatt-Rosen, O., Caplen, N.J., et al. (2004). Short interfering RNAs can induce unexpected and divergent changes in the levels of untargeted proteins in mammalian cells. Proc. Natl. Acad. Sci. U.S.A. 101, 1892-1897. (Pubitemid 38228987)
35. Scherr, M., Battmer, K., Winkler, T., et al. (2003). Specific inhibition of bcr-abl gene expression by small interfering RNA. Blood 101, 1566-1569. (Pubitemid 36182535)
36. Sledz, C.A., Holko, M., De Veer, M.J., et al. (2003). Activation of the interferon system by short-interfering RNAs. Nat. Cell Biol. 5, 834-839. (Pubitemid 37087172)
37. Stojdl, D.F., Lichty, B., Knowles, S., et al. (2000). Exploiting tumor-specific defects in the interferon pathway with a previously unknown oncolytic virus. Nat. Med. 6, 821-825. (Pubitemid 30469434)
38. Sun, Y., Li, Z., Li, L., et al. (2007). Effective inhibition of hepatitis B virus replication by small interfering RNAs expressed from human foamy virus vectors. Int. J. Mol. Med. 19, 705-711.
39. Taylor, J.A., Vojtech, L., Bahner, I., et al. (2008). Foamy virus vectors expressing anti-HIV transgenes efficiently block HIV-1 replication. Mol. Ther. 16, 46-51.
40. ter Brake, O. and Berkhout, B. (2007). Lentiviral vectors that carry anti-HIV shRNAs: problems and solutions. J. Gene Med. 9, 743-750. (Pubitemid 47386859)
41. Tiscornia, G., Singer, O., Ikawa, M., and Verma, I.M. (2003). A general method for gene knockdown in mice by using lentiviral vectors expressing small interfering RNA. Proc. Natl. Acad. Sci. U.S.A. 100, 1844-1848. (Pubitemid 36254536)
42. Trobridge, G., Josephson, N., Vassilopoulos, G., et al. (2002a). Improved foamy virus vectors with minimal viral sequences. Mol. Ther. 6, 321-328. (Pubitemid 36305333)
43. Trobridge, G., Vassilopoulos, G., Josephson, N., and Russell, D.W. (2002b). Gene transfer with foamy virus vectors. Methods Enzymol. 346, 628-648. (Pubitemid 41103164)
44. Trobridge, G.D., Allen, J., Peterson, L., et al. (2009). Foamy and lentiviral vectors transduce canine long-term repopulating cells at similar efficiency. Hum. Gene Ther. 20, 519-523.
45. Vassilopoulos, G., Trobridge, G., Josephson, N.C., and Russell, D.W. (2001). Gene transfer into murine hematopoietic stem cells with helper-free foamy virus vectors. Blood 98, 604-609.
46. Wang, L.J., Chen, Y.M., George, D., et al. (2002). Engraftment assessment in human and mouse liver tissue after sexmismatched liver cell transplantation by real-time quantitative PCR for Y chromosome sequences. Liver Transpl. 8, 822-828. (Pubitemid 35012294)
47. Wilda, M., Fuchs, U., Woessmann, W., and Borkhardt, A. (2002). Killing of leukemic cells with a BCR/ABL fusion gene by RNA interference (RNAi). Oncogene 21, 5716-5724.
48. Zhao, N., Zu, Z.X., Liu, C.M., et al. (2004). Knockdown of mouse adult beta-globin gene expression in MEL cells by retrovirus vector-mediated RNAinterference.Mol. Biotechnol. 28, 195-199.